Menu
← Oncology Approval Tracker
FDA DECISION ·
Tecvayli
teclistamab-cqyv · Janssen Biotech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Monotherapy for adults with relapsed or refractory multiple myeloma after at least four prior lines, including a proteasome inhibitor, an immunomodulatory drug and an anti-CD38 monoclonal antibody.
LAMPGEN ANALYSIS
Why it matters
This converts the original later-line monotherapy indication to traditional approval. The combination approved the same day has a different therapy-line threshold.
What research teams should watch
Verify exposure to all three specified drug classes. Use the monotherapy label and the correct evidence when discussing step-up dosing and safety obligations.
PRIMARY RECORDS